News headlines about Zeltiq Aesthetics (NASDAQ:ZLTQ) have been trending somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Zeltiq Aesthetics earned a coverage optimism score of 0.19 on Accern’s scale. Accern also assigned news headlines about the medical equipment provider an impact score of 46.2880957079089 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near term.
Shares of Zeltiq Aesthetics (ZLTQ) remained flat at $56.48 during trading on Friday. The firm’s 50-day moving average price is $56.05 and its 200-day moving average price is $46.95. Zeltiq Aesthetics has a 12-month low of $23.58 and a 12-month high of $56.50.
Zeltiq Aesthetics Company Profile
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. The Company’s product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists and obstetrics and gynecology (OBGYN) physicians.
Receive News & Ratings for Zeltiq Aesthetics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc and related companies with MarketBeat.com's FREE daily email newsletter.